Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
4.720
-0.540 (-10.27%)
At close: Sep 18, 2026, 4:00 PM EDT
4.660
-0.060 (-1.27%)
After-hours: Sep 18, 2026, 7:49 PM EDT
Niki BioSolutions Market Cap
Niki BioSolutions has a market cap or net worth of $13.87 million as of September 18, 2026. Its market cap has increased by 7.87% in one year.
Market Cap
13.87M
Enterprise Value
15.54M
1-Year Change
7.87%
Ranking
Category
Stock Price
$4.72
ChartMarket Cap Chart
Since December 18, 2018, Niki BioSolutions's market cap has decreased from $415.79M to $13.87M, a decrease of -96.66%. That is a compound annual growth rate of -35.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 13.87M | 60.68% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 14.67M |
| Moleculin Biotech | 14.41M |
| Enlivex | 14.18M |
| GT Biopharma | 14.09M |
| Pluri | 14.07M |
| Quoin Pharmaceuticals | 13.86M |
| Adial Pharmaceuticals | 13.76M |
| Vyome Holdings | 13.69M |